R. Kobelt

Factor VIII products and inhibitor development in severe hemophilia A.

R. Ljung, E. Santagostino, J. G. van der Bom, 2013, The New England journal of medicine.

Pharmacokinetic Profile of Nifedipine GITS in Hypertensive Patients with Chronic Renal Impairment

E. Brendel, R. Kobelt, A. Iaina, 2012, Drugs.

Long‐term follow‐up of neonatal intracranial haemorrhage in children with severe haemophilia

R. Ljung, M. Carcao, R. Wu, 2020, British journal of haematology.

Prophylactic treatment of haemophilia patients with inhibitors: clinical experience with recombinant factor VIIa in European Haemophilia Centres

J. Blatny, G. Auerswald, M. Morfini, 2007, Haemophilia : the official journal of the World Federation of Hemophilia.

Morning versus evening administration of nifedipine gastrointestinal therapeutic system in the management of essential hypertension

P. Suter, P. Greminger, R. Kobelt, 1994, The clinical investigator.

Treatment of children with haemophilia in Europe: a survey of 20 centres in 16 countries

M. Siimes, R. Ljung, H. Chambost, 2000, Haemophilia : the official journal of the World Federation of Hemophilia.

Intracranial haemorrhage in children and adolescents with severe haemophilia A or B – the impact of prophylactic treatment

G. Auerswald, R. Ljung, M. Carcao, 2017, British journal of haematology.

[Severe and moderate haemophilia under prophylactic replacement treatment--maximal knee extensor and flexor torque of children and adolescents].

L. Donath, C. Puta, M. Herbsleb, 2012, Hamostaseologie.

Twenty four hour intermittent, ambulatory blood pressure monitoring.

R. Kobelt, M. Bianchetti, M. Gnädinger, 1987, Archives of disease in childhood.